Page last updated: 2024-08-24

estradiol 3,17-disulfate and Adrenal Cortex Cancer

estradiol 3,17-disulfate has been researched along with Adrenal Cortex Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aichler, M; Candida Villares Fragoso, M; Fassnacht, M; Feuchtinger, A; Gill, AJ; Herterich, S; Kircher, S; Kroiss, M; Kunzke, T; Ronchi, CL; Sbiera, S; Schlegel, N; Sun, N; Walch, A; Waldmann, J; Weigand, I; Whitsett, TG1

Other Studies

1 other study(ies) available for estradiol 3,17-disulfate and Adrenal Cortex Cancer

ArticleYear
Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging.
    Clinical chemistry, 2019, Volume: 65, Issue:10

    Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Biomarkers, Tumor; Child; Estradiol; Estrone; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Steroids; Sulfotransferases; Young Adult

2019